Entera Bio EB613 Positioned to be First Oral Bone-Building Agent for OsteoporosisTreatment
Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, held a conference call on June 30th on results from its successfully completed Phase…
Continue Reading
Entera Bio EB613 Positioned to be First Oral Bone-Building Agent for OsteoporosisTreatment